Susquehanna International Group, LLP Arcellx, Inc. Put Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$50.91 - $86.61 $2.33 Million - $3.97 Million	45,800 Added 88.76%	97,400 $8.13 Million
Q2 2024 Aug 15, 2024	SELL	$49.74 - $66.98 $3.14 Million - $4.23 Million	-63,200 Reduced 55.05%	51,600 $2.85 Million
Q1 2024 May 07, 2024	BUY	$51.85 - $73.49 $5.51 Million - $7.8 Million	106,200 Added 1234.88%	114,800 $7.98 Million
Q4 2023 Feb 14, 2024	BUY	$31.75 - $57.99 $273,050 - $498,714	8,600 New	8,600 $477,000

204

44.2M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.47B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.